Integrated Wealth Concepts’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7K Hold
23,940
– – ﹤0.01% 2389
2026
Q1
$16.6K Buy
23,940
+2,000
+9% +$1.48K ﹤0.01% 2263
2025
Q4
$15.6K Sell
21,940
-92
-0.4% -$125 ﹤0.01% 1596
2025
Q3
$35.7K Sell
22,032
-3,906
-15% -$3.93K ﹤0.01% 1958
2025
Q2
$15.9K Sell
25,938
-1,379
-5% -$702 ﹤0.01% 1890
2025
Q1
$15.6K Buy
27,317
+3,377
+14% +$3.33K ﹤0.01% 1724
2024
Q4
$34.2K Buy
23,940
+7,000
+41% +$15.7K ﹤0.01% 1698
2024
Q3
$32.7K Buy
16,940
+1,940
+13% +$5.48K ﹤0.01% 1650
2024
Q2
$46.5K Hold
15,000
– – ﹤0.01% 1617
2024
Q1
$78.5K Hold
15,000
– – ﹤0.01% 1596
2023
Q4
$48.6K Buy
15,000
+5,000
+50% +$10.8K ﹤0.01% 1563
2023
Q3
$25.5K Hold
10,000
– – ﹤0.01% 1533
2023
Q2
$58.7K Sell
10,000
-5,000
-33% -$29.1K ﹤0.01% 1510
2023
Q1
$43K Buy
15,000
+5,000
+50% +$14.1K ﹤0.01% 1306
2022
Q4
$20K Buy
+10,000
New +$24.4K ﹤0.01% 1020

Other funds holding TNYA

Integrated Wealth Concepts's TNYA Position: Q2 2026 in Review

Integrated Wealth Concepts held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 23,940 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2389.

Integrated Wealth Concepts first reported a position in TNYA in Q4 2022 and has held it in 15 quarters since. The position peaked at $78.5K in Q1 2024. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Integrated Wealth Concepts held 23,940 shares of Tenaya Therapeutics worth $17.7K as of Q2 2026.
  • Integrated Wealth Concepts left its Tenaya Therapeutics share count unchanged in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #2389 holding.
  • Integrated Wealth Concepts first reported a position in Tenaya Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • Integrated Wealth Concepts's Tenaya Therapeutics position peaked at $78.5K in Q1 2024.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.